PDS Biotechnology Corp Increase (Decrease) in Other Receivables
PDS Biotechnology Corp (PDSB) reported Increase (Decrease) in Other Receivables of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2017-03-02
- PDS Biotechnology Corp increase (decrease) in other receivables for the quarter ending 2015-12-31 was $0.00.
- PDS Biotechnology Corp increase (decrease) in other receivables for the quarter ending 2014-12-31 was $0.00.
- PDS Biotechnology Corp increase (decrease) in other receivables for fiscal 2016 was $0.00.
- PDS Biotechnology Corp increase (decrease) in other receivables for fiscal 2015 was $0.00.
- PDS Biotechnology Corp increase (decrease) in other receivables for fiscal 2014 was -$459.02K, a 200.00% decline from fiscal 2013.
- PDS Biotechnology Corp increase (decrease) in other receivables for fiscal 2013 was $459.02K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-02 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 10-K · filed 2017-03-02 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$459.02K 10-K · filed 2017-03-02 | |
| 2014-09-30 | -$459.02K 10-Q · filed 2015-11-06 | ||
| 2013-12-31 | $459.02K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |